Naturally Splendid Enterprises Ltd. (TSXV:NS,FWB:50N,OTCQB:NSPDF), through its wholly owned subsidiary Naturally Splendid Enterprises USA Ltd., has signed a letter of intent with Full Spectrum Laboratories Ltd. to license Full Spectrum’s cannabinoid extraction and patented formulation technologies. Full Spectrum is headquartered in Dublin, Ireland.
As quoted in the press release:
The license will grant Naturally Splendid USA worldwide rights to a suite of advanced cannabinoid technologies, including the first issued USPTO patent for water-soluble cannabinoids, essential for the development and manufacturing of cannabinoid-based nutraceutical and pharmaceutical products and therapies. The license will allow Naturally Splendid USA to create products and industrial solutions in those countries and jurisdictions that allow for the manufacture and distribution of cannabinoid based products.
Naturally Splendid CEO Craig Goodwin said:
The Company continues to maximize revenue opportunities relating to cannabis sativa, which includes industrial hemp and marijuana. We have established a growing retail brand, NATERA™, that is being marketed across Canada and pushing into the United States based on the natural, nutritious foundation of industrial hemp. Now, through this worldwide licensing agreement with FSL we have positioned the company’s wholly-owned American subsidiary to capitalize on the exploding demand for cannabinoid-based products and solutions. Initially, Naturally Splendid USA will focus on the American market where hemp extracted cannabinoid products are allowed, and in the 23 states that allow for marijuana extracted cannabinoid products.